Results 1 to 10 of about 4,777 (186)

Increased Serologic Reactivity With Automated CMIA Testing and Its Implications for Deceased Donor Eligibility Determination in the United States [PDF]

Cell and Tissue Banking
Abstract Background In the United States, the use of Food & Drug Administration (FDA)-licensed, approved, or cleared tests is required for infectious disease screening and determining the eligibility of deceased donors for all Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps).
Dionne SO, Akana HCSR, Real M, Elliott KA, O'Neale BR.   +4 more
exaly   +4 more sources

Serum norethisterone (NET) levels in NET-enanthate (NET-EN) injectable contraception users substantially interfere with testosterone immunoassay measurements and confound interpretation of biological outcomes [PDF]

Contraception and Reproductive Medicine
Background The progestin norethisterone (NET), which is structurally related to testosterone, and its enanthate form (NET-EN), are used in contraception in women.
Chanel Avenant, Johnson Mosoko Moliki, Alexis J. Bick, Sigcinile Dlamini, Mandisa Singata-Madliki, G. Justus Hofmeyr, Pai-Lien Chen, Karl-Heinz Storbeck, Donita J. Africander, David W. Erikson, Janet P. Hapgood   +10 more
doaj   +3 more sources

Comparison of Chemiluminescent Microparticle Immunoassay (CMIA) With Electrochemiluminescence Immunoassay (ECLIA) for Carcinoembryonic Antigen (CEA)

Journal of Health Sciences, 2018
Introduction: Carcinoembryonic antigen (CEA) is used for monitoring of disease progression and treatment response in cancer patients.
Nafija Serdarevic
exaly   +5 more sources

Comparison of Serological Methods for the Diagnosis of Toxoplasmosis in Pregnant Women [PDF]

Pathogens
Comparative evaluations of different serological methods for the diagnosis of toxoplasmosis in pregnant women remain limited, and the performance of indirect immunofluorescence assay (IFA), modified agglutination test (MAT), and chemiluminescent ...
Nássarah Jabur Lot Rodrigues, Danilo Alves de França, Benedito Donizete Menozzi, Aristeu Vieira da Silva, Joelcio Francisco Abbade, Helio Langoni   +5 more
doaj   +2 more sources

ELISA IgG Versus CMIA IgG for Detection of SARS-CoV-2-Specific Antibodies in COVID-19 Patients

Medical Journal of Dr D Y Patil Vidyapeeth, 2022
COVID-19 is an important coronavirus infection. The detection of SARS-CoV-2-specific antibodies is important in laboratory medicine. Several serological tests are available.
Pathum Sookaromdee, Viroj Wiwanitkit
exaly   +3 more sources

Comparative Analytical Performance and Clinical Agreement of Chemiluminescence Microparticle Immunoassay and Electrochemiluminescence Immunoassay for CA19-9: A Diagnostic Accuracy Study [PDF]

Diagnostics
Background: Carbohydrate antigen 19-9 (CA19-9) is widely used as a tumor marker for pancreatic and hepatobiliary malignancies. However, inter-assay variability may affect the interpretation of results.
Jongkonnee Wongpiyabovorn, Nasornthan Yutthakasaemsan, Sunida Vandelaer   +2 more
doaj   +2 more sources

Analytical and clinical performance evaluation of the Wantai chemiluminescence microparticle immunoassay on the Wan200 + analyzer for diagnosing HIV [PDF]

Scientific Reports
On September 1, 2019, China implemented the “Blood Station Technical Operation Procedures (2019 Edition),” specifying Enzyme-Linked Immunosorbent Assay (ELISA) and Chemiluminescent Immunoassay (CLIA) for serological testing.
Jianfeng Chen, Liyue Jiang, Ran Ju, Yitong Li, Fengtian Wang   +4 more
doaj   +2 more sources

Clinical Utility of Liquid Chromatography-Tandem Mass Spectrometry for Thyroglobulin Measurement in Comparison with Immunoradiometric Assay and Chemiluminescence Microparticle Immunoassay [PDF]

Endocrinology and Metabolism
Background The liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed to overcome interference from thyroglobulin autoantibodies (TgAb); however, it has not yet been implemented in Korea.
Hyunju Park, Eungjun Yoon, Sang-Mi Kim, Tae Hyuk Kim, Jae Hoon Chung, Soo-Youn Lee, Sun Wook Kim   +6 more
doaj   +2 more sources

The Analyzation and Clinical Evaluation of ECLIA and CMIA in the Detection of Treponema pallidum

Medicine (United States), 2017
To evaluate the clinical application value of electrochemiluminescence immunoassay analyzer (ECLIA) and chemiluminescent magnetic microparticle immunoassay (CMIA) in the detection of Treponema pallidum (TP).A total of 1225 patients in Peking University Third Hospital was enrolled from June 2014 to October 2014. ECLIA and CMIA were applied to detect the
Liyan Cui, Jiansuo Zhou
exaly   +3 more sources

Therapeutic vancomycin monitoring: a comparative analysis of high-performance liquid chromatography and chemiluminescent microparticle immunoassay methods in liver transplant recipients [PDF]

Frontiers in Pharmacology
BackgroundVancomycin is a glycopeptide antibiotic of choice for treating serious Gram-positive bacterial infections, including methicillin-resistant Staphylococcus aureus (MRSA).
Soha Azadi, Seyed Soroush Jalali, Seyed Soroush Jalali, Soliman Mohammadi-Samani, Soliman Mohammadi-Samani, Parisa Ghasemiyeh, Parisa Ghasemiyeh, Bita Geramizadeh, Bita Geramizadeh, Hamed Nikoupour, Hamed Nikoupour, Afsaneh Vazin, Mojtaba Shafiekhani, Mojtaba Shafiekhani, Mojtaba Shafiekhani   +14 more
doaj   +2 more sources